| |
| |
|
| Insider
Information: |
Macphee John A |
| Relationship: |
Director |
| City: |
Woodcliff Lake |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
105,903 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
105,903 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Par Pharmaceutical Companies Inc |
PRX |
EVP, Pres-Strativa |
2011-01-11 |
105,903 |
|
0 |
Premium* |
|
|
Adamas Pharmaceuticals Inc |
ADMS |
Director |
2021-11-24 |
0 |
2020-06-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ADMS |
Adamas Pharmaceuticals In... |
Director |
– • – |
2021-11-24 |
4 |
D |
$0.00 |
$0 |
D/D |
(202,000) |
0 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
Director |
– • – |
2021-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
202,000 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
Director |
– • – |
2021-03-12 |
4 |
OE |
$0.67 |
$127,680 |
D/D |
192,000 |
197,000 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
Director |
– • – |
2020-06-03 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
5,000 |
0 |
- |
|
| PRX |
Par Pharmaceutical Compan... |
EVP, Pres-Strativa |
• – – |
2011-01-11 |
4 |
D |
$35.98 |
$683,836 |
D/D |
(19,006) |
105,903 |
0 |
- |
|
| PRX |
Par Pharmaceutical Compan... |
EVP, Pres-Strativa |
• – – |
2011-01-11 |
4 |
A |
$0.00 |
$0 |
D/D |
21,603 |
124,909 |
0 |
- |
|
| PRX |
Par Pharmaceutical Compan... |
EVP, Pres-Strativa |
• – – |
2011-01-04 |
4 |
D |
$39.79 |
$43,769 |
D/D |
(1,100) |
103,306 |
0 |
- |
|
| PRX |
Par Pharmaceutical Compan... |
EVP, Pres-Strativa |
• – – |
2010-12-20 |
4 |
D |
$38.26 |
$89,796 |
D/D |
(2,347) |
104,406 |
0 |
- |
|
| PRX |
Par Pharmaceutical Compan... |
EVP, Pres-Strativa |
• – – |
2010-11-18 |
4 |
D |
$37.72 |
$491,982 |
D/D |
(13,043) |
105,989 |
0 |
- |
|
| PRX |
Par Pharmaceutical Compan... |
EVP, Pres-Strativa |
• – – |
2010-03-22 |
4 |
D |
$25.09 |
$43,456 |
D/D |
(1,732) |
119,032 |
0 |
- |
|
| PRX |
Par Pharmaceutical Compan... |
EVP, Pres-Strativa |
• – – |
2010-03-09 |
4/A |
S |
$25.03 |
$80,822 |
D/D |
(3,229) |
120,764 |
0 |
- |
|
| PRX |
Par Pharmaceutical Compan... |
EVP, Pres-Strativa |
• – – |
2010-03-09 |
4 |
S |
$24.87 |
$998,222 |
D/D |
(39,910) |
120,764 |
0 |
- |
|
| PRX |
Par Pharmaceutical Compan... |
EVP, Pres - Strativa |
• – – |
2010-01-11 |
4 |
D |
$25.80 |
$61,043 |
D/D |
(2,366) |
160,380 |
0 |
- |
|
| PRX |
Par Pharmaceutical Compan... |
EVP, Pres-Strativa |
• – – |
2010-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
11,729 |
162,746 |
0 |
- |
|
| PRX |
Par Pharmaceutical Compan... |
EVP, Pres-Strativa |
• – – |
2009-12-21 |
4 |
D |
$26.04 |
$47,054 |
D/D |
(1,807) |
151,017 |
0 |
- |
|
| PRX |
Par Pharmaceutical Compan... |
EVP, Pres-Strativa |
• – – |
2009-09-09 |
4 |
D |
$21.19 |
$13,307 |
D/D |
(628) |
152,502 |
0 |
- |
|
| PRX |
Par Pharmaceutical Compan... |
EVP, Pres-Strativa |
• – – |
2009-03-23 |
4 |
D |
$11.19 |
$19,381 |
D/D |
(1,732) |
152,057 |
0 |
- |
|
| PRX |
Par Pharmaceutical Compan... |
EVP, Pres-Strativa |
• – – |
2009-01-12 |
4 |
D |
$12.59 |
$12,804 |
D/D |
(1,017) |
153,789 |
0 |
- |
|
| PRX |
Par Pharmaceutical Compan... |
EVP, Pres.-Strativa |
• – – |
2009-01-09 |
4 |
D |
$12.83 |
$20,515 |
D/D |
(1,599) |
154,806 |
0 |
- |
|
| PRX |
Par Pharmaceutical Compan... |
EVP, Pres.-Strativa |
• – – |
2009-01-06 |
4 |
D |
$13.59 |
$6,741 |
D/D |
(496) |
156,405 |
0 |
- |
|
| PRX |
Par Pharmaceutical Compan... |
EVP, Pres-Strativa |
• – – |
2008-12-22 |
4 |
D |
$12.43 |
$22,461 |
D/D |
(1,807) |
156,432 |
0 |
- |
|
| PRX |
Par Pharmaceutical Compan... |
EVP, President, Strativa Pharm |
• – – |
2008-11-18 |
4 |
A |
$0.00 |
$0 |
D/D |
45,496 |
158,239 |
0 |
- |
|
| PRX |
Par Pharmaceutical Compan... |
EVP, Pres Strativa Pharma |
• – – |
2008-10-17 |
4 |
B |
$10.63 |
$79,709 |
D/D |
7,500 |
112,743 |
2.74 |
- |
|
| PRX |
Par Pharmaceutical Compan... |
EVP, Pres-Strativa Pharma |
• – – |
2008-09-09 |
4 |
D |
$14.22 |
$8,930 |
D/D |
(628) |
104,693 |
0 |
- |
|
| PRX |
Par Pharmaceutical Compan... |
EVP, Pres Strativa Pharma |
• – – |
2008-03-24 |
4 |
D |
$18.37 |
$31,817 |
D/D |
(1,732) |
103,802 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
